Analysis of selenium content in commercial dietetic products.

Eur J Clin Nutr

Dept. of Biological Sciences, Dublin Institute of Technology, Republic of Ireland.

Published: March 1990

Selenium (Se) is largely associated with the protein component of foods. The processing of elemental feeds and artificial formulations used in clinical dietetic practice can, therefore, result in significant losses of Se from these products and the Se status of patients consuming these feeds may be compromised. A selection of commercial formulas typically used for enteral feeding, and for patients with cystic fibrosis, phenylketonuria and maple syrup urine disease were analysed for Se micro-fluorimetrically. Low Se contents were found in all food supplements except for Peptisorbon (0.09 mg Se/2000 kcal) and Clinifeed Protein Rich (0.08 mg Se/2000 kcal) which contained adequate daily Se levels according to the American RDI. The results show that a number of feeds are low in Se, especially those used for patients with cystic fibrosis and maple syrup urine disease. An investigation of the Se status of patients on these formulations may indicate the need for Se supplementation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

status patients
8
patients cystic
8
cystic fibrosis
8
maple syrup
8
syrup urine
8
urine disease
8
se/2000 kcal
8
analysis selenium
4
selenium content
4
content commercial
4

Similar Publications

Importance: Pediatric obesity and hypertension are highly correlated. To mitigate both conditions, provision of counseling on nutrition, lifestyle, and weight to children with high blood pressure (BP) measurements is recommended.

Objective: To examine racial and ethnic disparities in receipt of nutrition, lifestyle, and weight counseling among patients with high BP at pediatric primary care visits stratified by patients' weight status.

View Article and Find Full Text PDF

Purpose: Trophoblast cell-surface antigen 2 (Trop2) is overexpressed in various solid tumors and contributes to tumor progression, while its expression remains low in normal tissues. Trop2-targeting antibody-drug conjugate (ADC), sacituzumab govitecan-hziy (Trodelvy), has shown efficacy in targeting this antigen. Leveraging the enhanced specificity of ADCs, we conducted the first immunoPET imaging study of Trop2 expression in gastric cancer (GC) and triple-negative breast cancer (TNBC) models using Zr-labeled Trodelvy ([Zr]Zr-DFO-Trodelvy).

View Article and Find Full Text PDF

Background And Objective: The global average life expectancy has been increasing steadily as the quality of healthcare continues to improve. However, there is a paucity of data looking at surgical fixation of thoracolumbar spine fractures in patients ≥80 years (super-elderly). Aim of this study is to look at whether there is higher rate of complications from surgical fixation of thoracolumbar fractures in this group of patients.

View Article and Find Full Text PDF

Background And Objectives: Jugular paragangliomas (JPG) pose a surgical challenge because of their vascularity and complex location. Stereotactic radiosurgery (SRS) offers a minimally invasive management for patients with JPG. Our aim was to evaluate outcomes of Gamma Knife radiosurgery (GKRS) for the treatment of JPG over the long term.

View Article and Find Full Text PDF

Background And Objectives: The risk-to-benefit ratio of transopercular awake resection for recurrent insular diffuse gliomas is poorly studied. We assessed feasibility, safety, and efficacy of awake surgical resection of recurrent insular diffuse gliomas in patients with previous treatments (resection and/or radiotherapy and/or chemotherapy and/or combination).

Methods: Observational, retrospective, single-institution cohort analysis (2010-2023) of 123 consecutive adult patients operated on for an insular diffuse glioma (2021 World Health Organization classification) under awake conditions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!